Literature DB >> 26063590

Plasma Homocysteine Levels Predict the Risk of Acute Cerebral Infarction in Patients with Carotid Artery Lesions.

Wei Wu1, Yi Guan1, Kan Xu1, Xi-Jia Fu1, Xiao-Feng Lei1, Li-Jian Lei1, Zhi-Qing Zhang1, Yan Cheng1, Yun-Qian Li2.   

Abstract

This study examined the association between elevated plasma homocysteine (Hcy) levels and the risk of acute cerebral infarction in patients with carotid artery lesions. A total of 78 patients were divided into two groups, the high Hcy group (n = 38; Hcy levels >15 umol/L) and the low Hcy group (n = 40; Hcy levels ≤15 umol/L). High-resolution B-mode ultrasounds were performed to assess intima media thickness (IMT), infarcts, plaques, and stenosis in the extracranial carotid artery of these patients. All patients underwent 3 T MR scanners to evaluate cerebral artery stenosis in the intracranial cerebral artery. The plasma Hcy levels did not show any statistically significant differences when comparisons were based on gender, age, blood pressure, diabetes, hyperlipidemia, and systolic and diastolic pressures. Importantly, the incidence of carotid plaque and severe stenosis of intracranial and extracranial artery were significantly higher in the high Hcy group compared to the low Hcy group. Pearson's test indicated that plasma Hcy levels positively correlated with IMT, total number of plaques and unstable plaques. Overall, the elevated plasma Hcy levels correlated with increased frequency of carotid plaque formation, extra- and intracranial arterial stenosis, and the degree of stenosis. In conclusion, we find a significant correlation between elevated plasma Hcy levels and the increased incidence of acute cerebral infarction in patients with carotid artery lesions.

Entities:  

Keywords:  Acute cerebral infarction; Blood pressure; Carotid plaque; Carotid stenosis; Homocysteine; Hyperlipidemia

Mesh:

Substances:

Year:  2015        PMID: 26063590     DOI: 10.1007/s12035-015-9226-y

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  41 in total

1.  Homocysteine and the risk of ischemic stroke in a triethnic cohort: the NOrthern MAnhattan Study.

Authors:  Ralph L Sacco; Kishlay Anand; Hye-Seung Lee; Bernadette Boden-Albala; Sally Stabler; Robert Allen; Myunghee C Paik
Journal:  Stroke       Date:  2004-09-02       Impact factor: 7.914

Review 2.  II. Cerebral infarction/transient ischemic attack (TIA).

Authors:  Yukito Shinohara; Takehiko Yanagihara; Koji Abe; Toshiki Yoshimine; Toshiyuki Fujinaka; Takayo Chuma; Fumio Ochi; Masao Nagayama; Akira Ogawa; Norihiro Suzuki; Yasuo Katayama; Akio Kimura; Kazuo Minematsu
Journal:  J Stroke Cerebrovasc Dis       Date:  2011 Jul-Aug       Impact factor: 2.136

3.  Carotid intima-media thickness in patients with slow coronary flow and its association with neutrophil-to-lymphocyte ratio: a preliminary report.

Authors:  Faruk Cingoz; Atila Iyisoy; Sait Demirkol; Mehmet Ali Sahin; Sevket Balta; Turgay Celik; Murat Unlu; Zekeriya Arslan; Mustafa Cakar; Ugur Kucuk; Seref Demirbas; Necmettin Kocak
Journal:  Clin Appl Thromb Hemost       Date:  2013-04-23       Impact factor: 2.389

4.  Homocysteine and risk of recurrent stroke.

Authors:  Gudrun Boysen; Thomas Brander; Hanne Christensen; Rolf Gideon; Thomas Truelsen
Journal:  Stroke       Date:  2003-04-17       Impact factor: 7.914

5.  Carotid intima-media thickness in coronary slow flow: relationship with plasma homocysteine levels.

Authors:  Halil Tanriverdi; Harun Evrengul; Seyhan Tanriverdi; Omur Kuru; Deniz Seleci; Yasar Enli; Asuman Kaftan; Mustafa Kilic
Journal:  Coron Artery Dis       Date:  2006-05       Impact factor: 1.439

6.  Coronary artery disease and risk of major vascular events after cerebral infarction.

Authors:  Pierre Amarenco; Philippa C Lavallée; Julien Labreuche; Gregory Ducrocq; Jean-Michel Juliard; Laurent Feldman; Lucie Cabrejo; Elena Meseguer; Céline Guidoux; Valérie Adraï; Samina Ratani; Jérôme Kusmierek; Bertrand Lapergue; Isabelle F Klein; Fernando Gongora-Rivera; Arturo Jaramillo; Halim Abboud; Jean-Marc Olivot; Mikael Mazighi; Pierre-Jean Touboul; Philippe Gabriel Steg
Journal:  Stroke       Date:  2013-04-18       Impact factor: 7.914

7.  Middle cerebral artery plaque imaging using 3-Tesla high-resolution MRI.

Authors:  Kuniyasu Niizuma; Hiroaki Shimizu; Shihomi Takada; Teiji Tominaga
Journal:  J Clin Neurosci       Date:  2008-08-13       Impact factor: 1.961

8.  Evaluation of Homocysteine Level as a Risk Factor among Patients with Ischemic Stroke and Its Subtypes.

Authors:  Nahid Ashjazadeh; Morteza Fathi; Abdohamid Shariat
Journal:  Iran J Med Sci       Date:  2013-09

9.  Association of genotypes at the matrix metalloproteinase (MMP) loci with carotid IMT and presence of carotid and femoral atherosclerotic plaques.

Authors:  Andrie G Panayiotou; Maura B Griffin; Theodosis Tyllis; Niki Georgiou; Dawn Bond; Steve E Humphries; Andrew N Nicolaides
Journal:  Vasc Med       Date:  2013-09-16       Impact factor: 3.239

10.  Population PK/PD model of homocysteine concentrations after high-dose methotrexate treatment in patients with acute lymphoblastic leukemia.

Authors:  Hauke Rühs; Achim Becker; Anne Drescher; John C Panetta; Ching-Hon Pui; Mary V Relling; Ulrich Jaehde
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

View more
  14 in total

1.  Hyperhomocysteinemia is a risk factor for postoperative ischemia in adult patients with moyamoya disease.

Authors:  Junsheng Li; Peicong Ge; Qian Zhang; Fa Lin; Rong Wang; Yan Zhang; Dong Zhang; Wen Wang; Jizong Zhao
Journal:  Neurosurg Rev       Date:  2021-01-27       Impact factor: 3.042

2.  Efficacy of metoprolol plus atorvastatin for carotid atherosclerosis and its influence on carotid intima-media thickness and homocysteine level.

Authors:  Qiuping Chen; Linglong Fan; Yunshu Xu
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

3.  Acute Thrombolytic Therapy Combined with the Green Channel Can Reduce the Thrombolytic Time and Improve Neurological Function in Acute Stroke Patients.

Authors:  Zhen Hong; Mingming Zheng; Yan Li; Shaoquan Li; Qingran Liu; Songwang Xie; Junyong Wang; Jian Wang; Yongchang Liu
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-27       Impact factor: 2.650

4.  Study on the Association of Homocysteine and C-Reactive Protein with Neurofunctional Changes in Patients with Acute Ischemic Stroke After Endovascular Stent Treatment.

Authors:  Qiong Chen; Wen-Tong Ling; Deng-Ke Han
Journal:  Neuropsychiatr Dis Treat       Date:  2022-04-13       Impact factor: 2.989

5.  Clinical significance and efficacy analysis of atorvastatin in the treatment of patients with cerebral infarction and aspiration pneumonia.

Authors:  Bing Wei; Yugeng Liu
Journal:  Exp Ther Med       Date:  2018-10-04       Impact factor: 2.447

6.  Plasma homocysteine levels and intracranial plaque characteristics: association and clinical relevance in ischemic stroke.

Authors:  Shan Shan Lu; Jun Xie; Chun Qiu Su; Song Ge; Hai Bin Shi; Xun Ning Hong
Journal:  BMC Neurol       Date:  2018-12-06       Impact factor: 2.474

7.  Sequential butylphthalide therapy combined with dual antiplatelet therapy in the treatment of acute cerebral infarction.

Authors:  Xuewen Wo; Jinyan Han; Jiajia Wang; Xinmin Wang; Xiaoying Liu; Zhonggong Wang
Journal:  Pak J Med Sci       Date:  2020 May-Jun       Impact factor: 1.088

8.  Homocysteine, interleukin-1β, and fasting blood glucose levels as prognostic markers for diabetes mellitus complicated with cerebral infarction and correlated with carotid intima-media thickness.

Authors:  Zhenxiang Dai; Yang Jiao; Qingxian Fan; Anning Qi; Liang Xiao; Jingwei Li
Journal:  Exp Ther Med       Date:  2019-12-13       Impact factor: 2.447

9.  miR-124 Is Downregulated in Serum of Acute Cerebral Infarct Patients and Shows Diagnostic and Prognostic Value.

Authors:  Xiaojuan Zhou; Lizhong Qi
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

10.  Single nucleotide polymorphism of MTHFR rs1801133 associated with elevated Hcy levels affects susceptibility to cerebral small vessel disease.

Authors:  Hongyu Yuan; Man Fu; Xianzhang Yang; Kun Huang; Xiaoyan Ren
Journal:  PeerJ       Date:  2020-02-20       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.